Early Growth Response Protein-1 Involves in Transforming Growth factor-β1 Induced Epithelial-Mesenchymal Transition and Inhibits Migration of Non-Small-Cell Lung Cancer Cells |
Shan, Li-Na
(The First Affiliated Hospital of Liaoning Medical University)
Song, Yong-Gui (Jiangxi University of Traditional Chinese Medicine) Su, Dan (Jiangxi University of Traditional Chinese Medicine) Liu, Ya-Li (Jiangxi University of Traditional Chinese Medicine) Shi, Xian-Bao (The First Affiliated Hospital of Liaoning Medical University) Lu, Si-Jing (The First Affiliated Hospital of Liaoning Medical University) |
1 | Acevedo VD, Gangula RD, Freeman KW, et al (2007). Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer cell, 12, 559-71. DOI |
2 | BARON V, DUSS S, RHIM J, Mercola D (2003). Antisense to the Early Growth Response-1 Gene (Egr-1) Inhibits Prostate Tumor Development in TRAMP Mice. Ann N Y Acad Sci, 1002, 197-216. DOI |
3 | De Craene B, Berx G (2013). Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer, 13, 97-110. DOI |
4 | Farrell J, Kelly C, Rauch J, et al (2014). HGF induces epithelialto-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. J Proteome Res, 13, 2874-86. DOI |
5 | Fu M, Zhang J, Lin Y, et al (2003). Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPARgamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads. Biochem J, 370, 1019-25. DOI |
6 | Gorelik L, Flavell RA (2001). Immune-mediated eradication of tumors through the blockade of transforming growth factor- signaling in T cells. Nat Med, 7, 1118-22. DOI |
7 | Haslehurst AM, Koti M, Dharsee M, et al (2012). EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC cancer, 12, 91. DOI ScienceOn |
8 | Huang RP, Fan Y, De Belle I, et al (1997). Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer, 72, 102-9. DOI |
9 | Li H, Xu L, Li C, et al (2014). Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Mol Cancer, 13, 136. DOI |
10 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. DOI ScienceOn |
11 | Liu J, Liu YG, Huang R, et al (2007). Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells. Cancer Genomics Proteomics, 4, 377-85. |
12 | Liu Y, Zhou YD, Xiao YL, et al (2015). Cyr61/CCN1 Overexpression Induces Epithelial-Mesenchymal Transition Leading to Laryngeal Tumor Invasion and Metastasis and Poor Prognosis. Asian Pac J Cancer Prev, 16, 2659-64. DOI |
13 | Lo HW, Hsu SC, Xia W, et al (2007). Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res, 67, 9066-76. DOI |
14 | Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection (Yadanzi) combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4. DOI ScienceOn |
15 | McLeod C, Thornley A, Veale R, Scott E (1990). The anchorage-dependent and-independent growth of a human SCC cell line: the roles of TGF alpha/EGF and TGF beta. Br J Cancer, 61, 267. DOI |
16 | Moon Y, Lee M, Yang H (2007). Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Biochem Pharmacol, 73, 125-35. DOI |
17 | Padua D, Massague J (2009). Roles of TGF in metastasis. Cell Res, 19, 89-102. DOI ScienceOn |
18 | Sanchez-Elsner T, Botella LM, Velasco B, et al (2001). Synergistic cooperation between hypoxia and transforming growth factor- pathways on human vascular endothelial growth factor gene expression. J Biol Chem, 276, 38527-35. DOI |
19 | Parra E, Gutierrez L, Ferreira J (2013). Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor. Oncol Rep, 30, 911-6. |
20 | Portella G, Cumming SA, Liddell J, et al (1998). Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ, 9, 393-404. |
21 | Serrano-Martinez I, McDonald PC, Dedhar S (2012). The integrin-linked kinase (ILK)/Rictor complex is required for TGF {beta}-1-induced epithelial to mesenchymal transition (EMT). Cancer Res, 72, 324. DOI |
22 | Shin SY, Kim JH, Baker A, Lim Y, Lee YH (2010). Transcription factor egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor. Mol Cancer Res, 8, 507-19. DOI |
23 | Sukhatme VP, Cao X, Chang LC, et al (1988). A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell, 53, 37-43. DOI |
24 | Sun S, Ning X, Zhai Y, et al (2014). Egr-1 Mediates Chronic Hypoxia-Induced Renal Interstitial Fibrosis via the PKC/ERK Pathway. Am J Nephrol, 39, 436-48. |
25 | Thiel G, Mayer SI, Muller I, Stefano L, Rossler OG (2010). Egr-1-A Ca 2+-regulated transcription factor. Cell calcium, 47, 397-403. DOI |
26 | Thiery JP, Acloque H, Huang RY, Nieto MA (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-90. DOI |
27 | Yan HA, Shen K, Huang XE (2013). Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4801-4. DOI ScienceOn |
28 | Vetter G, Le Bechec A, Muller J, et al (2009). Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition. Biochem Biophys Res Commun, 385, 485-91. DOI |
29 | Virolle T, Krones-Herzig A, Baron V, et al (2003). Egr1 promotes growth and survival of prostate cancer cells identification of novel Egr1 target genes. J Biol Chem, 278, 11802-10. DOI |
30 | Yu H, Shen Y, Hong J, et al (2015). The contribution of TGF- in Epithelial-Mesenchymal Transition (EMT): Down-regulation of E-cadherin via snail. Neoplasma, 62, 1-15. DOI |
31 | Zhang H, Chen X, Wang J, et al (2014). EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression. Scientific reports, 4. |
32 | Zhu QC, Gao RY, Wu W, Qin HL (2013). Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev, 14, 2689-98. DOI ScienceOn |